Evidence map›Paper›PMID 41030045›Full record

ArticleEndocrinology2025

SALL1 Is an Orchestrator of Uterine Receptivity in Part via Titration of Estrogen Signaling.

Meade Haller, Yan Yin, Jeannine Basta, Lynn Robbins, Ian Hagemann, Ariel Wu, Patricia Jimenez, Michael Rauchman, Liang Ma

Abstract read
In one paragraph

Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meade HallerDivision of Dermatology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-6083-7660
Yan YinDivision of Dermatology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jeannine BastaDivision of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Lynn RobbinsResearch Service, VA Saint Louis Health Care System, St. Louis, MO 63106, USA.
Ian HagemannDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Ariel WuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Patricia JimenezDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Michael RauchmanDivision of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Liang MaDivision of Dermatology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-8013-4903

Funding

Retinoic acid signaling in decidualizationR01HD106120 · NICHD · WASHINGTON UNIVERSITY · PI MA, LIANG · 2021 to 2025
$1.7M
Androgen and Wnt signaling in bladder cancerR21CA283677 · NCI · WASHINGTON UNIVERSITY · PI MA, LIANG · 2023 to 2024
$383k
NCI NIH HHS R21 CA283677NICHD NIH HHS R01 HD106120NIH HHS R01DK298789NIH HHS R01HD106120NIH HHS R21CA283677
6 · The paper itself

Abstract

SALL1 is a critical regulator of embryonic development across a wide swath of tissues, including vital organs, but little is known about its function in adult tissues. Recent work from our group demonstrates that SALL1 is involved in urogenital development. This study delineates the role of SALL1 transcription factor in the adult reproductive system by demonstrating its requirement at multiple levels of uterine function during the implantation phase of early pregnancy. By generating a conditional knockout mouse model of Sall1 exclusively in female reproductive organs, it is demonstrated here that SALL1 is independently required both in the uterine luminal epithelium for the attachment of competent blastocysts to the uterine wall and in the uterine stroma for the process of decidualization, another prerequisite for pregnancy success. This robust, multitissue-layer requirement for SALL1 across multiple stages in the process of implantation makes it a newly identified regulator of early pregnancy. Here, it is shown that loss of SALL1 causes misexpression of estrogen receptor α during the window of implantation, and subsequent pathological deregulation of multiple estrogen response genes whose tight titrations are prerequisites of pregnancy. RNA sequencing of independent knockout uterine compartments at multiple timepoints, and chromatin immunoprecipitation sequencing to identify direct transcriptional targets, elucidated multiple powerful regulatory pathways downstream of SALL1. Importantly, the use of a selective estrogen receptor antagonist, fulvestrant, at a precise timepoint and dose, offers a partial rescue of embryo attachment to the uterine luminal epithelium, further demonstrating that SALL1 is upstream of estrogen receptor α during implantation phase signaling.

Indexed as

Embryo ImplantationEstrogensTranscription FactorsUterusAnimalsEstrogen Receptor alphaFemaleMiceMice, KnockoutPregnancySignal TransductionEstrogen Receptor alphaEstrogensSall1 protein, mouseTranscription FactorsChIP-seqdecidualizationestrogen signalingfulvestrantimplantationSALL1

Identifiers

PMID41030045
PMCPMC13622980

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.